Clinical Trial Update: Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) [Phase 3]

View source ↗

Summary

Phase 3 trial update on teduglutide for short bowel syndrome, reporting safety and efficacy in subjects who completed the protocol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-04-23